Comparing robotic and manual methods for treating kidney stones

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness, safety, and ergonomics of the ILY robotic system compared to manual flexible ureteroscopy (fURS) in treating kidney stones through laser lithotripsy. Adult participants will be randomly assigned to receive either robotic-assisted or manual ureteroscopy, with assessments conducted before and after the procedure. The study will focus on comparing clinical outcomes, complication rates, and the ergonomic advantages of using robotic technology in this context.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Males or females ≥ 18 years old
* Patients with a normal pelvicalyceal anatomy
* Patients with renal stone diagnosis confirmed by noncontrast computed tomography regardless of stone size, location, and multiplicity
* ASA score I-III
* Intact mental and cognitive ability to provide informed consent and willingness to participate in the study with 30-day follow-up

Exclusion Criteria:

* Children \< 18 and pregnant women
* Patients with anatomically anomalous kidneys, known case of stricture or stenosis, or recent 3-month history of ureteroscopy (DJ stent placement only will be accepted) or known history of complicated ureteroscopy
* Patients in whom stone measurement was not feasible on NCCT or those with concomitant ureteric stones.
* ASA score IV
* Mentally incapacitated patients unable to provide informed consent

Where it's running

• American University of Beirut Medical Center
  Beirut, Lebanon Recruiting

Study contacts

• Study coordinator: Albert El Hajj, MD
• Email: ae67@aub.edu.lb
• Phone: +961-1-350000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MODULITH SLX-F2 shockwave treatment with StorM-Track versus standard targeting for kidney stones

  This will test if using StorM-Track real-time stone tracking with the MODULITH SLX-F2 shockwave machine helps adults with 6–15 mm kidney stones become stone-free more often than standard shockwave treatment.

  Recruiting Storz Medical AG · Stockholm · NCT07272720

• Stone clearance with steerable ureteroscopic evacuation compared with other methods

  This study tests whether the CVAC/SURE approach helps clear kidney stones more effectively than standard renal-stone interventions in patients needing ureteroscopy or PCNL.

  Recruiting at 10 sites Calyxo, Inc. · Miami, Florida and 9 other locations · NCT07155005

• Steerable Ureteroscopic Renal Evacuation (SURE) with CVAC vs standard ureteroscopy

  This trial tests whether the SURE system with CVAC can improve outcomes compared with standard ureteroscopy with laser lithotripsy for kidney stones in adult patients.

  Recruiting at 6 sites Calyxo, Inc. · Birmingham, Alabama and 5 other locations · NCT07101809

• Investigating oxalate production in patients with calcium oxalate kidney stones

  This study is testing if people with calcium oxalate kidney stones produce more oxalate in their bodies than healthy individuals by following a special diet and taking certain supplements.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama and 1 other locations · NCT06989320

• Acupressure to Ease Pain During ESWL for Kidney Stones

  This study tests whether applying acupressure to specific points before ESWL can reduce pain and improve comfort for adults with kidney or proximal ureteral stones.

  Recruiting Medipol University · Istanbul · NCT07885696

• Audio consent with human voice or AI-voice added to written consent for ureteroscopy

  This study tests if listening to an audio version of the consent form, read by a real urologist or by an AI-cloned voice, helps adults in Turkey understand their ureteroscopy or RIRS consent better than the written form alone.

  Recruiting at 3 sites Aydin Adnan Menderes University · Aydin, Aydın and 2 other locations · NCT07859436

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.